A detailed history of Bridges Investment Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Bridges Investment Management Inc holds 84,971 shares of JNJ stock, worth $12.3 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
84,971
Previous 86,997 2.33%
Holding current value
$12.3 Million
Previous $12.7 Million 8.3%
% of portfolio
0.19%
Previous 0.2%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$145.48 - $167.38 $294,742 - $339,111
-2,026 Reduced 2.33%
84,971 $13.8 Million
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $5.35 Million - $5.85 Million
37,054 Added 74.19%
86,997 $12.7 Million
Q1 2024

Apr 25, 2024

SELL
$155.22 - $162.74 $887,082 - $930,059
-5,715 Reduced 10.27%
49,943 $7.9 Million
Q4 2023

Jan 23, 2024

BUY
$145.6 - $158.88 $384,384 - $419,443
2,640 Added 4.98%
55,658 $8.72 Million
Q3 2023

Oct 24, 2023

SELL
$155.75 - $174.48 $1.01 Million - $1.14 Million
-6,506 Reduced 10.93%
53,018 $8.26 Million
Q2 2023

Jul 07, 2023

SELL
$154.35 - $166.11 $1.4 Million - $1.51 Million
-9,063 Reduced 13.21%
59,524 $9.85 Million
Q1 2023

Apr 28, 2023

SELL
$151.05 - $180.26 $496,803 - $592,875
-3,289 Reduced 4.58%
68,587 $10.6 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $719,298 - $807,257
-4,490 Reduced 5.88%
71,876 $12.7 Million
Q3 2022

Oct 21, 2022

SELL
$161.33 - $179.52 $737,923 - $821,124
-4,574 Reduced 5.65%
76,366 $12.5 Million
Q2 2022

Jul 12, 2022

SELL
$168.19 - $186.01 $2.01 Million - $2.22 Million
-11,930 Reduced 12.85%
80,940 $14.4 Million
Q1 2022

Apr 08, 2022

SELL
$158.14 - $179.59 $4.34 Million - $4.93 Million
-27,450 Reduced 22.81%
92,870 $16.5 Million
Q4 2021

Feb 01, 2022

SELL
$155.93 - $173.01 $762,965 - $846,537
-4,893 Reduced 3.91%
120,320 $20.6 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $203,005 - $225,593
-1,257 Reduced 0.99%
125,213 $20.2 Million
Q2 2021

Jul 19, 2021

SELL
$159.48 - $171.07 $1.28 Million - $1.37 Million
-8,009 Reduced 5.96%
126,470 $20.8 Million
Q1 2021

May 05, 2021

SELL
$153.07 - $170.48 $2.42 Million - $2.69 Million
-15,780 Reduced 10.5%
134,479 $22.1 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $370,471 - $425,240
-2,702 Reduced 1.77%
150,259 $23.6 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $51,519 - $56,455
367 Added 0.24%
152,961 $22.8 Million
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $494,888 - $597,469
-3,842 Reduced 2.46%
152,594 $21.5 Million
Q1 2020

May 12, 2020

SELL
$111.14 - $153.99 $875,005 - $1.21 Million
-7,873 Reduced 4.79%
156,436 $20.5 Million
Q4 2019

Feb 18, 2020

SELL
$127.5 - $146.44 $2.44 Million - $2.8 Million
-19,125 Reduced 10.43%
164,309 $24 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $507,546 - $568,275
-3,998 Reduced 2.13%
183,434 $23.7 Million
Q2 2019

Aug 07, 2019

SELL
$131.15 - $144.24 $3.15 Million - $3.46 Million
-24,016 Reduced 11.36%
187,432 $26.1 Million
Q1 2019

May 01, 2019

SELL
$125.72 - $139.79 $407,332 - $452,919
-3,240 Reduced 1.51%
211,448 $29.6 Million
Q4 2018

Feb 11, 2019

BUY
$122.84 - $147.84 $2.55 Million - $3.07 Million
20,789 Added 10.72%
214,688 $27.7 Million
Q3 2018

Nov 15, 2018

BUY
$121.58 - $142.88 $436,836 - $513,367
3,593 Added 1.89%
193,899 $26.8 Million
Q2 2018

Aug 15, 2018

BUY
$119.4 - $131.76 $981,229 - $1.08 Million
8,218 Added 4.51%
190,306 $23.1 Million
Q1 2018

Apr 25, 2018

BUY
$125.1 - $148.14 $8.66 Million - $10.3 Million
69,229 Added 61.34%
182,088 $23.3 Million
Q4 2017

Feb 09, 2018

BUY
$131.22 - $143.62 $1.05 Million - $1.14 Million
7,966 Added 7.59%
112,859 $15.8 Million
Q3 2017

Oct 05, 2017

BUY
$129.47 - $135.38 $5.29 Million - $5.53 Million
40,837 Added 63.75%
104,893 $13.6 Million
Q3 2017

Oct 02, 2017

BUY
$129.47 - $135.38 $8.29 Million - $8.67 Million
64,056
64,056 $8.33 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Bridges Investment Management Inc Portfolio

Follow Bridges Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridges Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bridges Investment Management Inc with notifications on news.